NCT06206239View on ClinicalTrials.gov

Evaluation of Barriers to Cancer Care Delivery and Outcomes for Women of Color With Metastatic Breast Cancer

CompletedOBSERVATIONAL
Enrollment

44

Participants

Timeline

Start Date

March 9, 2022

Primary Completion Date

March 31, 2023

Study Completion Date

March 31, 2024

Conditions
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Breast Carcinoma
Trial Locations (1)

19107

Thomas Jefferson University, Philadelphia

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Thomas Jefferson University

OTHER

NCT06206239 - Evaluation of Barriers to Cancer Care Delivery and Outcomes for Women of Color With Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter